NeuroTimone Facility (PFNT)

The PFNT Facility is a coherent set of exploration tools in neurobiology allowing research at the molecular, cellular and integrated levels.

NCIS / PImaNT

PINT

qPCR

SCeNT

News

  1. Two recently published papers from the glioME team

    Tue. Feb 01 2022

    Plasmatic MMP9 released from tumor-infiltrating neutrophils is predictive for bevacizumab efficacy in glioblastoma patients: an AVAglio ancillary study

  2. Welcome to Guillaume, a new Master 2 student in the Nivet Team!

    Wed. Jan 05 2022

    We are please to welcome Guillaume Benhora-Chabeaux for his 5-month Master internship (2nd year) in the Nivet team. After obtaining a first Master degree in Cognitive Science (MASCO) from the Aix-Marseille University, with the highest honours, Guillaume has enrolled the Master in Neuroscience (cellular and molecular neuroscience). Guillaume will be working on the crosstalk between inflammation and a susceptibility to neurodegeneration using in vitro and in vivo models.
  3. Emmanuel Nivet (Team 6) is a new member of the European Scientific Advisory Board

    Tue. Jan 04 2022

    Dr Emmanuel Nivet has been appointed as a new member of the European Scientific Advisory Board (SAB) of a joint organization unifying the Alzheimer Forschung Initiative e.V. (AFI), Germany, Alzheimer Nederland (AN), The Netherlands and Fondation Vaincre Alzheimer (FVA), France. Each of the above organizations is dedicated to funding dementia research in its own country.
  4. Zoom sur la 5ème édition de la classification de l'OMS des tumeurs du Système Nerveux Central

    Thu. Dec 02 2021

    Membre expert du comité éditorial et co-auteur de plusieurs chapitres de la 5ème édition de la Classification des tumeurs du SNC de l’OMS parue le 12 novembre dernier, Dominique Figarella-Branger (Equipe 8 GlioME) a dirigé la rédaction d'un article de revue en français sur cette nouvelle classification, récemment publié dans les Annales de Pathologie: https://authors.elsevier.com/c/1eB1VtB1GOhjB

    Un article de référence, facile d'accès, pour toute personne souhaitant être à la page sur la classification des tumeurs du SNC!

  5. Recent works on Zinc binding to S100A1 and to NCS-1 published in Biomolecules and in  International Journal of Molecular Sciences respectively

    Fri. Dec 03 2021

    Team 9 (Cytoskeleton and Neurophysiopathology) and platform PINT (platform interactive Timone) are happy to see the almost simultaneous publications of two papers about about the impact of Zn2+ binding to NCS1 and to S100A1 respectively with their collaborators from Belozersky Institute of Physico Chemical Biology, Lomonosov Moscow State University, while the third one about Tau protein Zn2+ binding sites has been under review for already 3 months ... 
  6. New publication in Science Reports from Team 10

    Mon. Nov 08 2021

  7. New publication in Frontiers in Oncology

    Wed. Jan 06 2021

  8. Tau & Glioma : new article from INP team 9 and team 8 in Cancers

    Fri. Nov 19 2021

    The Cytoskeleton & Neurophysiopathology team and the GlioME team have a new publication out! Published on November 19th in Cancers, this article gives insights into how Tau regulates glioblastoma progression, via the PI3K-AKT signaling pathway. 

    Read the article here: https://www.mdpi.com/2072-6694/13/22/5818

Pages

INP in numbers

  • 126 members
  • 44 researchers
  • 48 research assistants
  • 12 post-docs
  • 11 PhD

 

Séminaire M&M’s – Muscle Monday Seminars of the Institute’s Myology Centre for Research

Within the cycle M&M’s – Muscle Monday Seminars of the Institute’s Myology Centre for Research, on January 17 Michel Khrestchatisky (CNRS Research Director, Director of the Institute for Neurophysiopathology) Co-Founder & Scientific Counsel of Vect-Horus presented the conference entitled “"Development of molecular vectors for targeted delivery of RNAi via receptor-mediated transport".

Undefined

VECT-HORUS reçoit un financement non dilutif de 1 M€ dans le cadre du dispositif de relance européen EACT-EU

Vect-Horus annonce l’accord de la Région SUD Provence-Alpes-Côte d’Azur, responsable de la mise en œuvre du dispositif REACT-EU dans le cadre du Programme Opérationnel FEDER-FSE, pour une subvention de plus d’un million d’euros. Ce projet est financé avec le concours de l’Union européenne avec le Fonds Européen de Développement Régional.

Pour plus d' information, lisez l'article complet dans BUSINESS WIRE.

Undefined

Welcome to Guillaume, a new Master 2 student in the Nivet Team!

We are please to welcome Guillaume Benhora-Chabeaux for his 5-month Master internship (2nd year) in the Nivet team. After obtaining a first Master degree in Cognitive Science (MASCO) from the Aix-Marseille University, with the highest honours, Guillaume has enrolled the Master in Neuroscience (cellular and molecular neuroscience). Guillaume will be working on the crosstalk between inflammation and a susceptibility to neurodegeneration using in vitro and in vivo models.

Undefined

Emmanuel Nivet (Team 6) is a new member of the European Scientific Advisory Board

Dr Emmanuel Nivet has been appointed as a new member of the European Scientific Advisory Board (SAB) of a joint organization unifying the Alzheimer Forschung Initiative e.V. (AFI), Germany, Alzheimer Nederland (AN), The Netherlands and Fondation Vaincre Alzheimer (FVA), France. Each of the above organizations is dedicated to funding dementia research in its own country.

Undefined

Zoom sur la 5ème édition de la classification de l'OMS des tumeurs du Système Nerveux Central

Membre expert du comité éditorial et co-auteur de plusieurs chapitres de la 5ème édition de la Classification des tumeurs du SNC de l’OMS parue le 12 novembre dernier, Dominique Figarella-Branger (Equipe 8 GlioME) a dirigé la rédaction d'un article de revue en français sur cette nouvelle classification, récemment publié dans les Annales de Pathologie: https://authors.elsevier.com/c/1eB1VtB1GOhjB

Undefined

Partners

                            

Aix-Marseille Université      

Aix Marseille Université | All rights reserved - Legal notice